Expression of endothelin-converting enzyme, endothelin-1 and endothelin receptors at the site of percutaneous coronary intervention in humans

Journal of Hypertension

Volumn 24, Issue 4, 2006, Pages 711-721

  Shirai, Nobuyuki ^a   Naruko, Takahiko ^b   Ohsawa, Masahiko ^a   Ikura, Yoshihiro ^a   Sugama, Yoshimi ^a   Hirayama, Michihiko ^a   Kitabayashi, Chizuko ^a   Ehara, Shoichi ^a   Inoue, Takeshi ^b   Itoh, Akira ^b   Haze, Kazuo ^b   Tanzawa, Kazuhiko ^c   Yoshiyama, Minoru ^a   Yoshikawa, Junichi ^a   Ueda, Makiko ^a  

^a OSAKA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b OSAKA CITY GENERAL HOSPITAL   (Japan)

^c DAIICHI SANKYO CO   (Japan)

Author keywords

Endothelin; Endothelin receptors; Endothelin converting enzyme; Restenosis; Smooth muscle cells

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; CD68 ANTIGEN; CYCLINE; ENDOTHELIN 1; ENDOTHELIN A RECEPTOR; ENDOTHELIN B RECEPTOR; ENDOTHELIN CONVERTING ENZYME; ENDOTHELIN RECEPTOR; KI 67 ANTIGEN; VON WILLEBRAND FACTOR;

ADULT; AGED; ARTICLE; ATHERECTOMY; AUTOPSY; CELL MIGRATION; CELL PROLIFERATION; CLINICAL ARTICLE; ENDOTHELIUM CELL; FEMALE; FROZEN SECTION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INTIMA; MACROPHAGE; MALE; MORPHOMETRICS; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; RESTENOSIS; SMOOTH MUSCLE FIBER; VASOCONSTRICTION;

EID: 33645528987     PISSN: 02636352     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.hjh.0000217854.97369.8c     Document Type: Article

References (45)

1. Lemos PA, Saia F, Ligthart JM, Arampatzis CA, Sianos G, Tanabe K, et al. Coronary restenosis after sirolimus-eluting stent implantation: morphological description and mechanistic analysis from a consecutive series of cases. Circulation 2003; 108:257-260.
2. Komatsu R, Ueda M, Naruko T, Kojima A, Becker AE. Neointimal tissue response at sites of coronary stenting in humans. Macroscopic, histological, and immunohistochemical analyses. Circulation 1998; 98:224-233.
3. Hoffmann R, Mintz GS, Dussaillant GR, Popma JJ, Richard AD, Satler LF, et al. Patterns and mechanisms of in-stent restenosis. A serial intravascular ultrasound study. Circulation 1996; 94:1247-1254.
4. Ueda M, Becker AE, Tsukada T, Numano F, Fujimoto T. Fibrocellular tissue response after percutaneous transluminal coronary angioplasty. An immunocytochemical analysis of the cellular composition. Circulation 1991; 83:1327-1332.
5. Naruko T, Ueda M, Becker AE, Tojo O, Teragaki M, Takeuchi T, et al. Angiographic-pathologic correlations after elective percutaneous transluminal coronary angioplasty. Circulation 1993; 88:1558-1568.
6. Ueda M, Becker AE, Kasayuki N, Kojima A, Morita Y, Tanaka S. In situ detection of platelet-derived growth factor-A and -B chain mRNA in human coronary arteries after percutaneous transluminal coronary angioplasty. Am J Pathol 1996; 149:831-843.
7. Yanagisawa M, Kurihara H, Kimura S, Tomobe Y, Kobayashi M, Mitsui Y, et al. A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature 1988; 332:411-415.
8. Hirata Y, Takagi Y, Fukuda Y, Marumo F. Endothelin is a potent mitogen for rat vascular smooth muscle cells. Atherosclerosis 1989; 78:225-228.
9. Douglas SA, Louden C, Vickery-Clark LM, Storer BL, Hart T, Feuerstein GZ, et al. A role for endogenous endothelin-1 in neointimal formation after rat carotid artery balloon angioplasty. Protective effects of the novel nonpeptide endothelin receptor antagonist SB 209670. Circ Res 1994; 75:190-197.
10. Xu D, Emoto N, Giaid A, Slaughter C, Kaw S, deWit D, et al. ECE-1: a membrane-bound metalloprotease that catalyzes the proteolytic activation of big endothelin-1. Cell 1994; 78:473-485.
11. Kimura S, Kasuya Y, Sawamura T, Shinimi O, Sugita Y, Yanagisawa M, et al. Conversion of big endothelin-1 to 21-residue endothelin-1 is essential for expression of full vasoconstrictor activity: structure-activity relationships of big endothelin-1. J Cardiovasc Pharmacol 1989; 13 (Suppl. 5):S5-S7.
12. Pons F, Touvay C, Lagente V, Mencia-Huerta JM, Braquet P. Bronchopulmonary and pressor activities of endothelin-1 (ET-1), ET-2, ET-3, and big ET-1 in the guinea pig. J Cardiovasc Pharmacol 1991; 17 (Suppl. 7):S326-S328.
13. Minamino T, Kurihara H, Takahashi M, Shimada K, Maemura K, Oda H, et al. Endothelin-converting enzyme expression in the rat vascular injury model and human coronary atherosclerosis. Circulation 1997; 95:221-230.
14. Maguire J, Davenport A. Increased response to big endothelin-1 in atherosclerotic human coronary artery: functional evidence for up-regulation of endothelin-converting enzyme activity in disease. Br J Pharmacol 1998; 125:238-240.
15. Ihling C, Szombathy T, Bohrmann B, Brockhaus M, Schaefer HE, Loeffler BM. Coexpression of endothelin-converting enzyme-1 and endothelin-1 in different stages of human atherosclerosis. Circulation 2001; 104:864-869.
16. Hai E, Ikura Y, Naruko T, Shirai N, Yoshimi N, Kayo S, et al. Alterations of endothelin-converting enzyme expression in early and advanced stages of human coronary atherosclerosis. Int J Mol Med 2004; 13:649-654.
17. Wang X, Douglas SA, Louden C, Vickery-Clark LM, Feuerstein GZ, Ohlstein EH. Expression of endothelin-1, endothelin-3, endothelin-converting enzyme-1, and endothelin-A and endothelin-B receptor mRNA after angioplasty-induced neointimal formation in the rat. Circ Res 1996; 78:322-328.
18. A receptor-mediated constrictor responses to endothelin peptides in human blood vessels in vitro. Br J Pharmacol 1995; 115:191-197.
19. Sakurai T, Yanagisawa M, Takuwa Y, Miyazaki H, Kimura S, Goto K, et al. Cloning of a cDNA encoding a non-isopeptide-selective subtype of the endothelin receptor. Nature 1990; 348:732-735.
20. B-like receptors. Biochem Biophys Res Commun 1992; 184:100-106.
21. Shimada K, Matsushita Y, Wakabayashi K, Takahashi M, Matsubara A, Iijima Y, et al. Cloning and functional expression of human endothelin-converting enzyme cDNA. Biochem Biophys Res Commun 1995; 207:807-812.
22. Tokunaga O, Fan J, Watanabe T, Kobayashi M, Kumazaki T, Mitsui Y. Endothelin. Immunohistologic localization in aorta and biosynthesis by cultured human aortic endothelial cells. Lab Invest 1992; 67:210-217.
23. B) receptor-deficient rats (aganglionosis rats). Eur J Neurosci 1998; 10:2984-2993.
24. Ueda M, Becker AE, Naruko T, Kojima A. Smooth muscle cell de-differentiation is a fundamental change preceding wound healing after percutaneous transluminal coronary angioplasty in humans. Coron Artery Dis 1995; 6:71-81.
25. Takagi M, Ueda M, Becker AE, Takeuchi K, Takeda T. The Watanabe heritable hyperlipidemic rabbit is a suitable experimental model to study differences in tissue response between intimal and medical injury after balloon angioplasty. Arterioscler Thromb Vasc Biol 1997; 17:3611-3619.
26. van der Loos CM, Becker AE, van den Oord JJ. Practical suggestions for successful immunoenzyme double-staining experiments. Histochem J 1993; 25:1-13.
27. Douglas SA, Ohlstein EH. Endothelin-1 promotes neointima formation after balloon angioplasty in the rat. J Cardiovasc Pharmacol 1993; 22 (Suppl. 8):S371-S373.
28. Hahn AW, Resink TJ, Scott-Burden T, Powell J, Dohi Y, Buhler FR. Stimulation of endothelin mRNA and secretion in rat vascular smooth muscle cells: a novel autocrine function. Cell Regul 1990; 9:649-659.
29. B receptor mRNAs after balloon angioplasty in the rat. J Cardiovasc Pharmacol 1995; 26 (Suppl. 3):S22-S25.
30. Naruko T, Ueda M, van der Wal AC, van der Loos CM, Itoh H, Nakao K, et al. C-type natriuretic peptide in human coronary atherosclerotic lesions. Circulation 1996; 94:3103-3108.
31. Inoue M, Itoh H, Ueda M, Naruko T, Kojima A, Komatsu R, et al. Vascular endothelial growth factor (VEGF) expression in human coronary atherosclerotic lesions: possible pathophysiological significance of VEGF in progression of atherosclerosis. Circulation 1998; 98:2108-2116.
32. B receptors mediate contraction to endothelin-1 in human blood vessels. Circulation 1994; 89:1203-1208.
33. Azuma H, Hamasaki H, Niimi Y, Terada T, Matsubara O. Role of endothelin-1 in neointima formation after endothelial removal in rabbit carotid arteries. Am J Physiol 1994; 267:H2259-H2267.
34. Ferrer P, Valentine M, Jenkins-West T, Weber H, Goller NL, Durham SK, et al. Orally active endothelin receptor antagonist BMS-182874 suppresses neointimal development in balloon-injured rat carotid arteries. J Cardiovasc Pharmacol 1995; 26:908-915.
35. Black SM, Bekker JM, Johengen MJ, Parry AJ, Soifer SJ, Fineman JR. Altered regulation of the ET-1 cascade in lambs with increased pulmonary blood flow and pulmonary hypertension. Pediatr Res 2000; 47:97-106.
36. Bauer M, Wimkins H, Langer F, Langer SO, Lausberg H, Lausberg JA, et al. Selective upregulation of endothelin B receptor gene expression in severe pulmonary hypertension. Circulation 2002; 105:1034-1036.
37. Black SM, Mata-Greenwood E, Dettman RW, Ovadia B, Fitzgerald RK, Reinhartz O, et al. Emergence of smooth muscle cell endothelin B-mediated vasoconstriction in lambs with experimental congenital heart disease and increased pulmonary blood flow. Circulation 2003; 108:1646-1654.
38. Kocker O, Gabbiani F, Gabbiani G, Reidy MA, Cokay MS, Peters H, et al. Phenotypic features of smooth muscle cells during the evolution of experimental carotid artery intimai thickening. Biochemical and morphologic studies. Lab Invest 1991; 65:459-470.
39. Hosono M, Ueda M, Suehiro S, Sasaki Y, Shibata T, Hattori K, et al. Neointimal formation at the sites of anastomosis of the internal thoracic artery grafts after coronary artery bypass grafting in human subjects: an immunohistochemical analysis. J Thorac Cardiovasc Surg 2000; 120:319-328.
40. Hasegawa K, Fujiwara H, Doyama K, Inada T, Ohtani S, Fujiwara T, et al. Endothelin-1 -selective receptor in the arterial intima of patients with hypertension. Hypertension 1994; 23:288-293.
41. Mintz GS, Popma JJ, Pichard AD, Kent KM, Satler LF, Wong C, et al. Arterial remodeling after coronary angioplasty: a serial intravascular ultrasound study. Circulation 1996; 94:35-43.
42. Hong MK, Mintz GS, Lee CW, Kim YH, Lee JW, Song JM. Intravascular ultrasound assessment of patterns of arterial remodeling in the absence of significant reference segment plaque burden in patients with coronary artery disease. J Am Coll Cardiol 2003; 42:806-810.
43. Hasegawa T, Ehara S, Kobayashi Y, Kataoka T, Yamashita H, Nishioka H, et al. Acute myocardial infarction: clinical characteristics and plaque morphology between expansive remodeling and constrictive remodeling by intravascular ultrasound. Am Heart J 2006; in press.
44. Costello KB, Stewart DJ, Baffour R. Endothelin is a potent constrictor of human vessels used in coronary revascularization surgery. Eur J Pharmacol 1990; 186:311-314.
45. Chester AH, O'Neil GS, Allen SP, Luu TN, Tadjkarimi S, Yacoub MH. Effect of endothelin on normal and diseased human coronary arteries. Eur J Clin Invest 1992; 22:210-213.